Anika announces strategic update of business with sale of arthrosurface and plan to divest parcus medical

Company to focus on profitable hyaluronic acid-driven oa pain management and high growth regenerative solutions portfolio, streamline operations and enhance growth profile company to focus on profitable hyaluronic acid-driven oa pain management and high growth regenerative solutions portfolio, streamline operations and enhance growth profile
ANIK Ratings Summary
ANIK Quant Ranking